e-ISSN 1694-2078
p-ISSN 1694-2086
  

Arch Med Biomed Res. 2014;1:79-89.

Okezie I Aruoma1, Darshini Narrain2, Joseph Indelicato3, Emmanuel Bourdon4, Fatima Murad5 and Theeshan Bahorun2

Author Affiliations

1Department of Pharmaceutical Sciences, School of Pharmacy, American University of Health Sciences, Signal Hill, CA 90755, USA
2ANDI Center for Biomedical and Biomaterials Research, University of Mauritius, MSIRI Building, Réduit, Republic of Mauritius
3Touro College of Health Sciences, Bay Shore, New York, NY 11706, USA
4Groupe d’Etude sur l’Inflammation Chronique et l’Obésité (GEICO), Université de La Réunion, Saint Denis, Plateforme CYROI, France
5Apollo Bramwell Hospital, Moka, Mauritius

correspondence to
OI Aruoma; oaruoma@auhs.edu
T Bahorun; tbahorun@uom.ac.mu

Received: March 3, 2014
Revised: May 8, 2014
Accepted: May 10, 2014

Abstract

Type 2 Diabetes Mellitus is associated with elevated blood glucose level, abnormal abdominal fat deposition, insulin resistance and a number of complications including embryopathy, cardiovascular diseases, nephropathy, neuropathy, microangiopathy and retinopathy. Complications extending to the central nervous system may have a deteriorating effect on mental health including a decline in cognitive functioning. This could be a reason for depression, lack of compliance towards medication/treatment, and the inability of patients to meet the day-to-day management demands of the disease. Due to the high metabolic demand for energy in the brain, perturbations in glucose metabolism can noticeably impact cognitive performance. This review discusses and enlightens on the factors contributing to cognitive impairment in Type 2 Diabetes Mellitus. An understanding of the mechanisms of diabetes-related cognitive impairment and the resulting behaviors of patients can help healthcare professionals implement treatments to significantly improve health status and quality of life of patients with diabetes.

KEY WORDS: Type 2 Diabetes Mellitus; Cognitive Impairment and Brain Function; Insulin and Brain Function; Diabetes Therapeutic Drugs and Compliance; Depression and Alzheimer’s Disease; Neuropsychopharmacology of Diabetes; Functional Foods and Human Diet; Quality of Life and Wellness
   
   
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.